Atomwise is an AI superplatform for drug discovery, whose core purpose is to use machine learning to explore vast chemical space and find novel, drug-like molecules that others have not yet discovered, thereby improving the efficiency of small-molecule drug discovery. The material mentions that projects produced by the platform have first-in-class and best-in-class potential in the field of immune and inflammatory diseases. The platform was built by a world-class team of scientists and engineers, aiming to redefine the way small-molecule drugs are discovered.
Its main capabilities are centered on using machine learning to mine undiscovered potential molecules in chemical space.
Information such as usage methods, specific operating steps, charging model, pricing, platform compatibility, available regions, and access permissions is not yet provided in the official materials. Applicable scenarios can be understood as early-stage small-molecule drug discovery research related to immune and inflammatory diseases, but more specific scope and limitations are not yet provided.